Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Die Radiologie
Erschienen in: Die Radiologie 11/2023

18.10.2023 | Magnetresonanztomografie | CME

Magnetresonanztomographie der Lunge

Stand der Dinge

verfasst von: Dr. med. Lena Wucherpfennig, Prof. Dr. med. Hans-Ulrich Kauczor, PD Dr. med. Monika Eichinger, Prof. Dr. med. Mark O. Wielpütz, MHBA EDIR EBIR

Erschienen in: Die Radiologie | Ausgabe 11/2023

zum CME-Kurs Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Lunge war lange Zeit aufgrund der geringen Protonendichte des Parenchyms sowie des schnellen Signalzerfalls an den Luft-Gewebe-Grenzen der Magnetresonanztomographie (MRT) schwer zugänglich. Technische Neuerungen haben diese Anforderungen größtenteils adressiert. Pulmonale Veränderungen, welche mit Gewebevermehrung einhergehen („Plus-Pathologien“), lassen sich nun aufgrund der lokal vermehrten Protonendichte mit einer hohen diagnostischen Genauigkeit darstellen. Die MRT bietet im Vergleich zur Computertomographie (CT) ein umfassendes Spektrum funktioneller Bildgebungsverfahren (Atemmechanik, Perfusion, Ventilation) sowie – als strahlungsfreie, nicht-invasive Untersuchungsmodalität – die Möglichkeit wiederholter Untersuchungen für Verlaufsbeurteilungen oder die Überwachung von Therapieeffekten, auch bei Kindern. In diesem Artikel besprechen wir technische Aspekte, geben Protokollvorschläge und erörtern die Rolle der Lungen-MRT in der routinemäßigen Beurteilung verschiedener Erkrankungen.
Literatur
1.
Wielpütz M, Kauczor HU (2012) MRI of the lung: state of the art. Diagn Interv Radiol 18:344–353PubMed
2.
Wielpütz MO, Triphan SMF, Ohno Y, Jobst BJ, Kauczor HU (2019) Outracing lung signal decay—potential of Ultrashort echo time MRI. Rofo 191:415–423PubMed
3.
Biederer J, Hintze C, Fabel M (2008) MRI of pulmonary nodules: technique and diagnostic value. Cancer Imaging 8:125–130PubMedPubMedCentral
4.
Ley-Zaporozhan J, Puderbach M, Kauczor HU (2008) MR for the evaluation of obstructive pulmonary disease. Magn Reson Imaging Clin N Am 16:291–308PubMed
5.
Iwasawa T, Takahashi H, Ogura T et al (2007) Correlation of lung parenchymal MR signal intensity with pulmonary function tests and quantitative computed tomography (CT) evaluation: a pilot study. J Magn Reson Imaging 26:1530–1536PubMed
6.
Biederer J, Beer M, Hirsch W et al (2012) MRI of the lung (2/3). Why ... when ... how? Insights Imaging 3:355–371PubMedPubMedCentral
7.
Fink C, Puderbach M, Biederer J et al (2007) Lung MRI at 1.5 and 3 Tesla: observer preference study and lesion contrast using five different pulse sequences. Invest Radiol 42:377–383PubMed
8.
Puderbach M, Hintze C, Ley S, Eichinger M, Kauczor HU, Biederer J (2007) MR imaging of the chest: a practical approach at 1.5T. Eur J Radiol 64:345–355PubMed
9.
Kluge A, Luboldt W, Bachmann G (2006) Acute pulmonary embolism to the subsegmental level: diagnostic accuracy of three MRI techniques compared with 16-MDCT. AJR Am J Roentgenol 187:W7–14PubMed
10.
Johnson KM, Fain SB, Schiebler ML, Nagle S (2013) Optimized 3D ultrashort echo time pulmonary MRI. Magn Reson Med 70:1241–1250PubMed
11.
Longuefosse A, Raoult J, Benlala I et al (2023) Generating high-resolution synthetic CT from lung MRI with ultrashort echo times: initial evaluation in cystic fibrosis. Radiology 308:e230052PubMed
12.
Plathow C, Fink C, Ley S et al (2004) Measurement of diaphragmatic length during the breathing cycle by dynamic MRI: comparison between healthy adults and patients with an intrathoracic tumor. Eur Radiol 14:1392–1399PubMed
13.
Fink C, Puderbach M, Bock M et al (2004) Regional lung perfusion: assessment with partially parallel three-dimensional MR imaging. Radiology 231:175–184PubMed
14.
Wielpütz MO, Puderbach M, Kopp-Schneider A et al (2014) Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease. Am J Respir Crit Care Med 189:956–965PubMed
15.
Eichinger M, Puderbach M, Fink C et al (2006) Contrast-enhanced 3D MRI of lung perfusion in children with cystic fibrosis—initial results. Eur Radiol 16:2147–2152PubMed
16.
Triphan SMF, Stahl M, Jobst BJ et al (2020) Echo time-dependence of observed lung T1 in patients with cystic fibrosis and correlation with clinical metrics. J Magn Reson Imaging 52:1645–1654PubMed
17.
Voskrebenzev A, Gutberlet M, Klimes F et al (2018) Feasibility of quantitative regional ventilation and perfusion mapping with phase-resolved functional lung (PREFUL) MRI in healthy volunteers and COPD, CTEPH, and CF patients. Magn Reson Med 79:2306–2314PubMed
18.
Jobst BJ, Triphan SM, Sedlaczek O et al (2015) Functional lung MRI in chronic obstructive pulmonary disease: comparison of T1 mapping, oxygen-enhanced T1 mapping and dynamic contrast enhanced perfusion. PLoS ONE 10:e121520PubMedPubMedCentral
19.
Ley S, Puderbach M, Risse F et al (2007) Impact of oxygen inhalation on the pulmonary circulation: assessment by magnetic resonance (MR)-perfusion and MR-flow measurements. Invest Radiol 42:283–290PubMed
20.
van Beek EJ, Wild JM, Kauczor HU, Schreiber W, Mugler JP 3rd, de Lange EE (2004) Functional MRI of the lung using hyperpolarized 3‑helium gas. J Magn Reson Imaging 20:540–554PubMed
21.
Mannino DM, Doherty DE, Buist SA (2006) Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 100:115–122PubMed
22.
Suga K, Tsukuda T, Awaya H et al (1999) Impaired respiratory mechanics in pulmonary emphysema: evaluation with dynamic breathing MRI. J Magn Reson Imaging 10:510–520PubMed
23.
Iwasawa T, Yoshiike Y, Saito K, Kagei S, Gotoh T, Matsubara S (2000) Paradoxical motion of the hemidiaphragm in patients with emphysema. J Thorac Imaging 15:191–195PubMed
24.
Heussel CP, Ley S, Biedermann A et al (2004) Respiratory lumenal change of the pharynx and trachea in normal subjects and COPD patients: assessment by cine-MRI. Eur Radiol 14:2188–2197PubMed
25.
Theissen IL, Meissner A (1996) Hypoxic pulmonary vasoconstriction. Anaesthesist 45:643–652PubMed
26.
Molinari F, Fink C, Risse F, Tuengerthal S, Bonomo L, Kauczor HU (2006) Assessment of differential pulmonary blood flow using perfusion magnetic resonance imaging: comparison with radionuclide perfusion scintigraphy. Invest Radiol 41:624–630PubMed
27.
Ohno Y, Hatabu H, Murase K et al (2004) Quantitative assessment of regional pulmonary perfusion in the entire lung using three-dimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: Preliminary experience in 40 subjects. J Magn Reson Imaging 20:353–365PubMed
28.
Schiwek M, Triphan SMF, Biederer J et al (2022) Quantification of pulmonary perfusion abnormalities using DCE-MRI in COPD: comparison with quantitative CT and pulmonary function. Eur Radiol 32:1879–1890PubMed
29.
Ohno Y, Sugimura K, Hatabu H (2003) Clinical oxygen-enhanced magnetic resonance imaging of the lung. Top Magn Reson Imaging 14:237–243PubMed
30.
Marshall H, Deppe MH, Parra-Robles J et al (2012) Direct visualisation of collateral ventilation in COPD with hyperpolarised gas MRI. Thorax 67:613–617PubMed
31.
Ley-Zaporozhan J, Ley S, Kauczor HU (2008) Morphological and functional imaging in COPD with CT and MRI: present and future. Eur Radiol 18:510–521PubMed
32.
Biederer J, Mirsadraee S, Beer M et al (2012) MRI of the lung (3/3)-current applications and future perspectives. Insights Imaging 3:373–386PubMedPubMedCentral
33.
Eichinger M, Heussel CP, Kauczor HU, Tiddens H, Puderbach M (2010) Computed tomography and magnetic resonance imaging in cystic fibrosis lung disease. J Magn Reson Imaging 32:1370–1378PubMed
34.
Wielpütz MO, Eichinger M, Biederer J et al (2016) Imaging of cystic fibrosis lung disease and clinical interpretation. Rofo 188:834–845PubMed
35.
Graeber SY, Zhou-Suckow Z, Schatterny J, Hirtz S, Boucher RC, Mall MA (2013) Hypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung disease. Am J Respir Cell Mol Biol 49:410–417PubMedPubMedCentral
36.
Biederer J, Both M, Graessner J et al (2003) Lung morphology: fast MR imaging assessment with a volumetric interpolated breath-hold technique: initial experience with patients. Radiology 226:242–249PubMed
37.
Puderbach M, Eichinger M, Gahr J et al (2007) Proton MRI appearance of cystic fibrosis: comparison to CT. Eur Radiol 17:716–724PubMed
38.
Rosenfeld M, Ratjen F, Brumback L et al (2012) Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. JAMA 307:2269–2277PubMedPubMedCentral
39.
Mentore K, Froh DK, de Lange EE, Brookeman JR, Paget-Brown AO, Altes TA (2005) Hyperpolarized HHe 3 MRI of the lung in cystic fibrosis: assessment at baseline and after bronchodilator and airway clearance treatment. Acad Radiol 12:1423–1429PubMed
40.
Altes TA, Johnson M, Fidler M et al (2017) Use of hyperpolarized helium‑3 MRI to assess response to ivacaftor treatment in patients with cystic fibrosis. J Cyst Fibros 16:267–274PubMed
41.
42.
Eichinger M, Optazaite DE, Kopp-Schneider A et al (2012) Morphologic and functional scoring of cystic fibrosis lung disease using MRI. Eur J Radiol 81:1321–1329PubMed
43.
44.
Graeber SY, Renz DM, Stahl M et al (2022) Effects of Elexacaftor/Tezacaftor/Ivacaftor therapy on lung clearance index and magnetic resonance imaging in patients with cystic fibrosis and one or two F508del alleles. Am J Respir Crit Care Med 206:311–320PubMed
45.
Leutz-Schmidt P, Optazaite DE, Sommerburg O et al (2023) Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosis. ERJ Open Res 9:
46.
Lederlin M, Bauman G, Eichinger M et al (2013) Functional MRI using fourier decomposition of lung signal: reproducibility of ventilation- and perfusion-weighted imaging in healthy volunteers. Eur J Radiol 82:1015–1022PubMed
47.
Bauman G, Puderbach M, Heimann T et al (2013) Validation of fourier decomposition MRI with dynamic contrast-enhanced MRI using visual and automated scoring of pulmonary perfusion in young cystic fibrosis patients. Eur J Radiol 82:2371–2377PubMed
48.
Thomen RP, Walkup LL, Roach DJ, Cleveland ZI, Clancy JP, Woods JC (2017) Hyperpolarized (129)Xe for investigation of mild cystic fibrosis lung disease in pediatric patients. J Cyst Fibros 16:275–282PubMed
49.
Höffken G, Lorenz J, Kern W et al (2009) Epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults. Guidelines of the Paul-Ehrlich-Society for Chemotherapy, the German Respiratory Society, the German Society for Infectiology and the Competence Network CAPNETZ Germany. Pneumologie 63:e1–68PubMed
50.
Dalhoff K, Abele-Horn M, Andreas S et al (2012) Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia. S‑3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy. Pneumologie 66:707–765PubMed
51.
Self WH, Courtney DM, McNaughton CD, Wunderink RG, Kline JA (2013) High discordance of chest x‑ray and computed tomography for detection of pulmonary opacities in ED patients: implications for diagnosing pneumonia. Am J Emerg Med 31:401–405PubMed
52.
Eibel R, Herzog P, Dietrich O et al (2006) Pulmonary abnormalities in immunocompromised patients: comparative detection with parallel acquisition MR imaging and thin-section helical CT. Radiology 241:880–891PubMed
53.
Peltola V, Ruuskanen O, Svedstrom E (2008) Magnetic resonance imaging of lung infections in children. Pediatr Radiol 38:1225–1231PubMed
54.
Biederer J, Busse I, Grimm J et al (2002) Sensitivity of MRI in detecting alveolar infiltrates: experimental studies. Rofo 174:1033–1039PubMed
55.
Konietzke P, Mueller J, Wuennemann F et al (2020) The value of chest magnetic resonance imaging compared to chest radiographs with and without additional lung ultrasound in children with complicated pneumonia. PLoS ONE 15:e230252PubMedPubMedCentral
56.
Lutterbey G, Grohe C, Gieseke J et al (2007) Initial experience with lung-MRI at 3.0T: comparison with CT and clinical data in the evaluation of interstitial lung disease activity. Eur J Radiol 61:256–261PubMed
57.
Yi CA, Lee KS, Han J, Chung MP, Chung MJ, Shin KM (2008) 3‑T MRI for differentiating inflammation- and fibrosis-predominant lesions of usual and nonspecific interstitial pneumonia: comparison study with pathologic correlation. Am J Roentgenol 190:878–885
58.
Brady D, Lavelle LP, McEvoy SH et al (2016) Assessing fibrosis in pulmonary sarcoidosis: late-enhanced MRI compared to anatomic HRCT imaging. Qjm 109:257–264PubMed
59.
Craig DA, Colletti PM, Ratto D, Gordonson JS, Raval JK, Sharma OP (1988) MRI findings in pulmonary sarcoidosis. Magn Reson Imaging 6:567–573PubMed
60.
Chung JH, Cox CW, Forssen AV, Biederer J, Puderbach M, Lynch DA (2014) The dark lymph node sign on magnetic resonance imaging: a novel finding in patients with sarcoidosis. J Thorac Imaging 29:125–129PubMed
61.
Stein PD, Fowler SE, Goodman LR et al (2006) Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 354:2317–2327PubMed
62.
Stein PD, Chenevert TL, Fowler SE et al (2010) Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med 152:434–443PubMedPubMedCentral
63.
Wucherpfennig L, Triphan SM, Weinheimer O et al (2023) Reproducibility of pulmonary magnetic resonance angiography in adults with muco-obstructive pulmonary disease. Acta Radiol 64:1038–1046PubMed
64.
Ersoy H, Goldhaber SZ, Cai T et al (2007) Time-resolved MR angiography: a primary screening examination of patients with suspected pulmonary embolism and contraindications to administration of iodinated contrast material. AJR Am J Roentgenol 188:1246–1254PubMed
65.
Peacock A, Simonneau G, Rubin L (2006) Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 3:608–614PubMed
66.
Pengo V, Lensing AW, Prins MH et al (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350:2257–2264PubMed
67.
Dartevelle P, Fadel E, Mussot S et al (2004) Chronic thromboembolic pulmonary hypertension. Eur Respir J 23:637–648PubMed
68.
Kreitner KF, Ley S, Kauczor HU et al (2004) Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques. Radiology 232:535–543PubMed
69.
Kluge A, Gerriets T, Lange U, Bachman G (2005) MRI for short-term follow-up of acute pulmonary embolism. Assessment of thrombus appearance and pulmonary perfusion: a feasibility study. Eur Radiol 15:1969–1977PubMed
70.
Ley S, Fink C, Zaporozhan J et al (2005) Value of high spatial and high temporal resolution magnetic resonance angiography for differentiation between idiopathic and thromboembolic pulmonary hypertension: initial results. Eur Radiol 15:2256–2263PubMed
71.
Regier M, Kandel S, Kaul MG et al (2007) Detection of small pulmonary nodules in high-field MR at 3 T: evaluation of different pulse sequences using porcine lung explants. Eur Radiol 17:1341–1351PubMed
72.
Baumann T, Ludwig U, Pache G et al (2008) Detection of pulmonary nodules with move-during-scan magnetic resonance imaging using a free-breathing turbo inversion recovery magnitude sequence. Invest Radiol 43:359–367PubMed
73.
Biederer J, Schoene A, Freitag S, Reuter M, Heller M (2003) Simulated pulmonary nodules implanted in a dedicated porcine chest phantom: sensitivity of MR imaging for detection. Radiology 227:475–483PubMed
74.
Meier-Schroers M, Homsi R, Skowasch D et al (2018) Lung cancer screening with MRI: results of the first screening round. J Cancer Res Clin Oncol 144:117–125PubMed
75.
Ohno Y, Koyama H, Yoshikawa T et al (2017) Standard-, reduced-, and no-dose thin-section radiologic examinations: comparison of capability for nodule detection and nodule type assessment in patients suspected of having pulmonary nodules. Radiology 284:562–573PubMed
76.
Hintze C, Biederer J, Wenz HW, Eberhardt R, Kauczor HU (2006) MRI in staging of lung cancer. Radiologe 46:251–254 (256–259)PubMed
77.
Hintze C, Dinkel J, Biederer J, Heussel CP, Puderbach M (2010) New procedures. Comprehensive staging of lung cancer by MRI. Radiologe 50:699–705PubMed
78.
Biederer J, Reuter M, Both M et al (2002) Analysis of artefacts and detail resolution of lung MRI with breath-hold T1-weighted gradient-echo and T2-weighted fast spin-echo sequences with respiratory triggering. Eur Radiol 12:378–384PubMed
79.
Ohno Y, Adachi S, Motoyama A et al (2001) Multiphase ECG-triggered 3D contrast-enhanced MR angiography: utility for evaluation of hilar and mediastinal invasion of bronchogenic carcinoma. J Magn Reson Imaging 13:215–224PubMed
80.
Pauls S, Mottaghy FM, Schmidt SA et al (2008) Evaluation of lung tumor perfusion by dynamic contrast-enhanced MRI. Magn Reson Imaging 26:1334–1341PubMed
81.
Ohno Y, Koyama H, Takenaka D et al (2008) Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2‑[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules. J Magn Reson Imaging 27:1284–1295PubMed
82.
Ohno Y, Koyama H, Nogami M et al (2007) STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N‑stage in non-small-cell lung cancer patients. J Magn Reson Imaging 26:1071–1080PubMed
83.
Ohno Y, Hatabu H, Takenaka D et al (2004) Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. Radiology 231:872–879PubMed
Metadaten
Titel
Magnetresonanztomographie der Lunge
Stand der Dinge
verfasst von
Dr. med. Lena Wucherpfennig
Prof. Dr. med. Hans-Ulrich Kauczor
PD Dr. med. Monika Eichinger
Prof. Dr. med. Mark O. Wielpütz, MHBA EDIR EBIR
Publikationsdatum
18.10.2023

Weitere Artikel der Ausgabe 11/2023

Die Radiologie 11/2023 Zur Ausgabe

Leitthema

Dynamische Magnetresonanztomographie des Beckenbodens: Technische Aspekte

Leitthema

Funktionell-neurochirurgische Therapieoptionen bei Funktionsstörungen des Beckenbodens

Einführung zum Thema

Bildgebung bei Erkrankungen des Beckenbodens

Leitthema

Praxistipps für die Sonographie des Beckenbodens

Leitthema

Bildgebung des Beckenbodens (MR-Defäkographie)

radClub

Patientenaufklärung 3.0

Weitere Lesetipps

ANZEIGE

Sichere Antikoagulation bei ständig wechselnden Risikokonstellationen

ANZEIGE

Krebsassoziierte Thrombosen – ein steigendes Problem

Offene Fragen beim frühen hormonrezeptor-positiven Mammakarzinom

Mit neuen Methoden der Gewebediagnostik das Tumormikromilieu ergründen

Erhöhtes Keratitis-Risiko unter EGFR-Inhibitor-Therapie

ANZEIGE

CAT-Management - Was gibt es Neues bei den NMH

Bildnachweise